Patent · US Active

Modified release tranexamic acid formulation

US9387178B2 · kind B2 · utility

4Cited by
4References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 19, 2013
Grant dateJul 12, 2016
Priority date—
Expiry dateJan 29, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P7/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A modified release dosage form for the oral administration of tranexamic acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.